Health-related Quality of Life Benefits of Arsenic Trioxide in Patients with Non-High-risk Acute Promyelocytic Leukemia Are Sustained over Time: Long-Term Results of the GIMEMA APL0406 Trial
Annals of hematology(2024)
Key words
Acute promyelocytic leukemia,Survivorship,Quality of life,Patient-reported outcomes,Arsenic trioxide,Clinical trial
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined